Alan Pollack

23.8k total citations · 5 hit papers
465 papers, 17.4k citations indexed

About

Alan Pollack is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Alan Pollack has authored 465 papers receiving a total of 17.4k indexed citations (citations by other indexed papers that have themselves been cited), including 335 papers in Pulmonary and Respiratory Medicine, 154 papers in Radiation and 93 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Alan Pollack's work include Prostate Cancer Diagnosis and Treatment (261 papers), Prostate Cancer Treatment and Research (250 papers) and Advanced Radiotherapy Techniques (154 papers). Alan Pollack is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (261 papers), Prostate Cancer Treatment and Research (250 papers) and Advanced Radiotherapy Techniques (154 papers). Alan Pollack collaborates with scholars based in United States, Canada and Israel. Alan Pollack's co-authors include Gunar K. Zagars, Deborah A. Kuban, Andrew C. von Eschenbach, George Starkschall, Eric M. Horwitz, Eugene Huang, Alexandra L. Hanlon, Isaac Rosen, Mark K. Buyyounouski and Lei Dong and has published in prestigious journals such as Science, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Alan Pollack

455 papers receiving 16.8k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial

2002 1.1k citations Alan Pollack, Gunar K. Zagars et al. International Journal of Radiation Oncology*Biology*Physics profile →
Long-Term Results of the M. D. Anderson Randomized Dose-Escalation Trial for Prostate Cancer

2007 938 citations Deborah A. Kuban, Alan Pollack et al. International Journal of Radiation Oncology*Biology*Physics profile →
Predicting the Outcome of Salvage Radiation Therapy for Recurrent Prostate Cancer After Radical Prostatectomy

2007 633 citations Howard M. Sandler, Jeffrey D. Forman et al. profile →
Randomized Trial of Hypofractionated External-Beam Radiotherapy for Prostate Cancer

2013 340 citations Alan Pollack, Eric M. Horwitz et al. profile →
Contemporary Update of a Multi-Institutional Predictive Nomogram for Salvage Radiotherapy After Radical Prostatectomy

2016 229 citations Matthew C. Abramowitz, Alan Pollack et al. profile →

Peers

Countries citing papers authored by Alan Pollack

Since Specialization

Citations

This map shows the geographic impact of Alan Pollack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Pollack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Pollack more than expected).

Fields of papers citing papers by Alan Pollack

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan Pollack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Pollack. The network helps show where Alan Pollack may publish in the future.

Co-authorship network of co-authors of Alan Pollack

This figure shows the co-authorship network connecting the top 25 collaborators of Alan Pollack. A scholar is included among the top collaborators of Alan Pollack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan Pollack. Alan Pollack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Uncovering prostate cancer aggressiveness signal in T2‐weighted MRI through a three‐reference tissues normalization technique 2023 ·NMR in Biomedicine ·Ahmad Algohary, Evangelia I. Zacharaki, (unknown), (unknown), (unknown), (unknown), Sandra M. Gaston, Sanoj Punnen, Patricia Castillo, Pradip M. Pattany, Oleksandr N. Kryvenko, Benjamin Spieler, Matthew C. Abramowitz, Alan Dal Pra, John C. Ford, Alan Pollack, Radka Stoyanova	2
2	Clinical-Genomic Risk Group Classification of Suspicious Lesions on Prostate Multiparametric-MRI 2023 ·Cancers ·Radka Stoyanova, Olmo Zavala‐Romero, Deukwoo Kwon, (unknown), (unknown), Ahmad Algohary, (unknown), Sandra M. Gaston, Patricia Castillo, Oleksandr N. Kryvenko, Elai Davicioni, Bruno Nahar, Benjamin Spieler, Matthew C. Abramowitz, Alan Dal Pra, Dipen J. Parekh, Sanoj Punnen, Alan Pollack	3
3	Classifying Malignancy in Prostate Glandular Structures from Biopsy Scans with Deep Learning 2023 ·Cancers ·(unknown), Dmitry B. Goldgof, Lawrence Hall, (unknown), Joseph Johnson, (unknown), Radka Stoyanova, Sanoj Punnen, Alan Pollack, Julio M. Pow‐Sang, Yoganand Balagurunathan	2
4	Radiation Attenuates Prostate Tumor Antiviral Responses to Vesicular Stomatitis Virus Containing IFNβ, Resulting in Pronounced Antitumor Systemic Immune Responses 2020 ·Molecular Cancer Research ·Thirupandiyur S. Udayakumar, (unknown), Anis Ahmad, Wensi Tao, Tulasigeri M. Totiger, Mausam Patel, Brian Marples, Glen N. Barber, Alan Pollack	20
5	Post-Treatment Biopsy Positivity In Prostate Cancer Patients Undergoing MpMRI-Targeted Radiation Dose Escalation 2020 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), (unknown), Radka Stoyanova, Alan Dal Pra, Matthew C. Abramowitz, Isildinha M. Reis, Deukwoo Kwon, Sanoj Punnen, Eric M. Horwitz, Alan Pollack	1
6	Acute Epithelial Toxicity Is Prognostic for Improved Prostate Cancer Response to Radiation Therapy: A Retrospective, Multicenter, Cohort Study 2018 ·International Journal of Radiation OncologyBiologyPhysics ·Thomas Eade, Ananya Choudhury, Alan Pollack, Matthew C. Abramowitz, (unknown), Linxin Guo, Jason Kennedy, Sandra Louw, George Hruby, Andrew Kneebone, Catharine West	6
7	Automatic Detection and Quantitative DCE-MRI Scoring of Prostate Cancer Aggressiveness 2017 ·Frontiers in Oncology ·Nestor A. Parra, Alan Pollack, (unknown), Matthew C. Abramowitz, Brian Marples, Felipe Múnera, Rosa Castillo, Oleksandr N. Kryvenko, Sanoj Punnen, Radka Stoyanova	15
8	Delineation of Tumor Habitats based on Dynamic Contrast Enhanced MRI 2017 ·Scientific Reports ·(unknown), Ellen Ackerstaff, (unknown), (unknown), Warren D. Foltz, Carl Fisher, Lothar Lilge, HyungJoon Cho, Sean Carlin, Robert J. Gillies, Yoganand Balagurunathan, Raphael Yechieli, Ty K. Subhawong, Barış Türkbey, Alan Pollack, Radka Stoyanova	50
9	Edelfosine Promotes Apoptosis in Androgen-Deprived Prostate Tumors by Increasing ATF3 and Inhibiting Androgen Receptor Activity 2016 ·Molecular Cancer Therapeutics ·Thirupandiyur S. Udayakumar, Radka Stoyanova, Mohammed M. Shareef, Zhaomei Mu, (unknown), Kerry L. Burnstein, Alan Pollack	13
10	Patient-Reported Quality of Life After Stereotactic Body Radiation Therapy Versus Moderate Hypofractionation for Clinically Localized Prostate Cancer 2016 ·International Journal of Radiation OncologyBiologyPhysics ·Skyler B. Johnson, Pamela R. Soulos, Timothy D. Shafman, C.A. Mantz, (unknown), (unknown), (unknown), Sean P. Collins, Simeng Suy, Jeffrey V. Brower, M.A. Ritter, Christopher King, Patrick A. Kupelian, Eric M. Horwitz, Alan Pollack, Matthew C. Abramowitz, M.A. Hallman, Sergio Faria, Cary P. Gross, James B. Yu	1
11	The Importance of Protein Kinase A in Prostate Cancer: Relationship to Patient Outcome in Radiation Therapy Oncology Group Trial 92-02 2009 ·Clinical Cancer Research ·Alan Pollack, Kyounghwa Bae, Li‐Yan Khor, Tahseen Al‐Saleem, M. Elizabeth H. Hammond, Varagur Venkatesan, Roger W. Byhardt, Sucha O. Asbell, William U. Shipley, Howard M. Sandler	24
12	Longitudinal associations among quality of life and its predictors in patients treated for prostate cancer: The moderating role of age 2008 ·Psychology Health & Medicine ·Michael A. Diefenbach, Nihal Mohamed, Eric M. Horwitz, Alan Pollack	26
13	Influence of Number of CAG Repeats on Local Control in the RTOG 86-10 Protocol 2006 ·American Journal of Clinical Oncology ·May Abdel–Wahab, Brian Berkey, Awtar Krishan, (unknown), Elizabeth Hammond, Mack Roach, C.A. Lawton, (unknown), Arnold M. Markoe, Alan Pollack	16
14	Identification of groups at risk for distant metastasis and death in men with a rising PSA after radiotherapy for prostate cancer 2004 ·International Journal of Radiation OncologyBiologyPhysics ·A.L. Hanlon, Eric M. Horwitz, (unknown), Alan Pollack	1
15	Intensity modulated radiation therapy (IMRT) is a cost-effective treatment for intermediate risk prostate cancer 2004 ·International Journal of Radiation OncologyBiologyPhysics ·André Konski, Deborah Watkins Bruner, (unknown), Alexandra L. Hanlon, S. Kulkarni, J. Robert Beck, Alan Pollack	5
16	Clinical staging of prostate cancer: Reproducibility and clarification of issues 2001 ·International Journal of Cancer ·Timothy Campbell, John C. Blasko, E. David Crawford, Jeffrey D. Forman, Gerald E. Hanks, Deborah A. Kuban, James E. Montie, Judd W. Moul, Alan Pollack, Derek Raghavan, Paul S. Ray, Mack Roach, Gary D. Steinberg, Nelson N. Stone, Ian M. Thompson, Nicholas J. Vogelzang, Srinivasan Vijayakumar	19
17	Simultaneous estimation ofTG2+M,TS, andTpot using single sample dynamic tumor data from bivariate DNA-thymidine analogue cytometry 2000 ·Cytometry ·(unknown), Marvin L. Meistrich, Alan Pollack, Nicholas H. A. Terry	23
18	Prostate specific antigen density as a prognostic factor for patients with prostate carcinoma treated with radiotherapy 1996 ·Cancer ·Alan Pollack, Scott P. Lankford, Gunar K. Zagars, R. Joseph Babaian	17
19	Chapter 3 Cell Cycle Phase-Specific Analysis of Cell Viability Using Hoechst 33342 and Propidium Iodide after Ethanol Preservation 1990 ·Methods in cell biology ·Alan Pollack, Gaetano Ciancio	44
20	Scialom pin implants. 1968 ·PubMed ·(unknown), (unknown), Alan Pollack	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact